Milestone Pharmaceuticals sets June 10, 2025 as annual meeting date; record date April 15

Milestone Pharmaceuticals Inc.

2025 annual meeting scheduled for June 10, 2025; record date for voting is April 15, 2025.
Shareholder proposals under Rule 14a-8 must be received by the company secretary by March 29, 2025.
Proposals under Quebec Business Corporations Act and company by-laws due by April 15, 2025.
Universal proxy rule notice for director nominations must be provided by April 11, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.